Free Trial

Genenta Science (GNTA) Short Interest Ratio & Short Volume

Genenta Science logo
$3.98 -0.01 (-0.13%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Genenta Science Short Interest Data

Genenta Science (GNTA) has a short interest of 1,300 shares, representing 0.01% of the float (the number of shares available for trading by the public). This marks a -13.33% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 14,781 shares to cover all short positions.

Current Short Interest
1,300 shares
Previous Short Interest
1,500 shares
Change Vs. Previous Month
-13.33%
Dollar Volume Sold Short
$4,985.50
Short Interest Ratio
0.1 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
18,290,000 shares
Short Percent of Float
0.01%
Today's Trading Volume
269 shares
Average Trading Volume
14,781 shares
Today's Volume Vs. Average
2%
Short Selling Genenta Science?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Genenta Science and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GNTA Short Interest Over Time

GNTA Days to Cover Over Time

GNTA Percentage of Float Shorted Over Time

Remove Ads

Genenta Science Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/20251,300 shares $4,985.50 -13.3%0.0%0.1 $3.84
2/28/20251,500 shares $5,850.00 -40.0%0.0%0.1 $3.90
2/15/20252,500 shares $10,925.00 -26.5%0.0%0.2 $4.37
1/31/20253,400 shares $11,968.00 +30.8%N/A0.3 $3.52
1/15/20252,600 shares $10,634.00 +18.2%N/A0.2 $4.09
12/31/20242,200 shares $9,570.00 -29.0%N/A0.1 $4.35
12/15/20243,100 shares $15,903.00 +121.4%N/A0.2 $5.13
11/30/20241,400 shares $7,280.00 -64.1%N/A0.1 $5.20
11/15/20243,900 shares $19,578.00 -26.4%N/A0.3 $5.02
10/31/20245,300 shares $27,030.00 -54.3%N/A0.4 $5.10
10/15/202411,600 shares $67,280.00 +152.2%N/A0.9 $5.80
9/30/20244,600 shares $19,642.46 -20.7%N/A0.3 $4.27
9/15/20245,800 shares $22,910.00 -40.8%N/A0.5 $3.95
8/31/20249,800 shares $37,926.00 -18.3%N/A0.8 $3.87
8/15/202412,000 shares $52,200.00 -14.9%N/A1.1 $4.35
7/31/202414,100 shares $60,628.59 +227.9%N/A1.2 $4.30
7/15/20244,300 shares $14,878.00 +4.9%N/A0.3 $3.46
6/30/20244,100 shares $12,710.00 -18.0%N/A1 $3.10
6/15/20245,000 shares $16,186.50 +47.1%N/A1.2 $3.24
5/31/20243,400 shares $11,662.00 +79.0%N/A0.6 $3.43
5/15/20241,900 shares $6,080.00 -60.4%N/A0.3 $3.20
4/30/20244,800 shares $14,784.00 +23.1%N/A0.8 $3.08
4/15/20243,900 shares $13,123.50 +30.0%N/A0.7 $3.37
3/31/20243,000 shares $10,500.30 -9.1%N/A0.7 $3.50
3/15/20243,300 shares $12,870.00 -5.7%N/A0.8 $3.90
2/29/20243,500 shares $15,399.65 -5.4%N/A1.2 $4.40
2/15/20243,700 shares $14,800.00 +5.7%N/A1.3 $4.00
1/31/20243,500 shares $14,105.00 -5.4%N/A1.3 $4.03
1/15/20243,700 shares $16,465.00 No ChangeN/A1.8 $4.45
12/31/20233,700 shares $18,315.00 -32.7%N/A1.7 $4.95
12/15/20235,500 shares $27,610.00 +14.6%N/A2.5 $5.02
11/30/20234,800 shares $23,760.00 -35.1%N/A2.4 $4.95
11/15/20237,400 shares $38,480.00 +37.0%N/A3.9 $5.20
10/31/20235,400 shares $28,836.00 -25.0%N/A3.2 $5.34
10/15/20237,200 shares $40,248.00 +1.4%N/A3.8 $5.59
9/30/20237,100 shares $36,565.00 +10.9%N/A4.4 $5.15
9/15/20236,400 shares $36,032.00 -1.5%N/A3.6 $5.63
8/31/20236,500 shares $37,700.00 -17.7%N/A3.2 $5.80
8/15/20237,900 shares $43,687.00 +9.7%N/A3.4 $5.53
7/31/20237,200 shares $39,168.00 +50.0%N/A3 $5.44
Musk’s real agenda in D.C. (Ad)

In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…

7/15/20234,800 shares $28,560.00 -14.3%N/A2.2 $5.95
6/30/20235,600 shares $32,984.00 +7.7%N/A2.7 $5.89
6/15/20235,200 shares $29,848.00 +300.0%N/A2.4 $5.74
5/31/20231,300 shares $7,932.73 -23.5%N/A0.5 $6.10
5/15/20231,700 shares $9,537.00 +54.6%N/A0.7 $5.61
4/30/20231,100 shares $6,600.00 +266.7%N/A0.4 $6.00
4/15/2023300 shares $1,890.00 No ChangeN/A0.1 $6.30
3/31/2023300 shares $1,725.00 -40.0%N/A0.1 $5.75
3/15/2023500 shares $3,350.00 -66.7%N/A0.1 $6.70
2/28/20231,500 shares $9,750.00 +114.3%N/A0.3 $6.50
2/15/2023700 shares $4,585.00 -22.2%N/A0.2 $6.55
1/31/2023900 shares $5,526.00 -50.0%N/A0.2 $6.14
1/15/20231,800 shares $11,610.00 -30.8%N/A0.4 $6.45
12/30/20222,600 shares $14,300.00 +116.7%N/A0.6 $5.50
12/15/20221,200 shares $6,780.00 +140.0%N/A0.4 $5.65
11/30/2022500 shares $2,605.00 -80.8%N/A0.2 $5.21
11/15/20222,600 shares $10,816.00 +225.0%N/A1.2 $4.16
10/31/2022800 shares $3,520.00 +33.3%N/A0.4 $4.40
10/15/2022600 shares $2,742.00 -25.0%N/A0.3 $4.57
9/30/2022800 shares $3,983.92 -11.1%N/A0.3 $4.98
9/15/2022900 shares $4,719.33 +125.0%N/A0.3 $5.24
8/31/2022400 shares $2,368.00 -71.4%N/A0.1 $5.92
8/15/20221,400 shares $8,876.00 -12.5%N/A0.4 $6.34
7/31/20221,600 shares $10,512.00 -46.7%N/A0.3 $6.57
7/15/20223,000 shares $20,220.00 No ChangeN/A0.6 $6.74

GNTA Short Interest - Frequently Asked Questions

What is Genenta Science's current short interest?

Short interest is the volume of Genenta Science shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 1,300 shares of GNTA short. 0.01% of Genenta Science's shares are currently sold short. Learn More on Genenta Science's current short interest.

What is a good short interest percentage for Genenta Science?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.01% of Genenta Science's floating shares are currently sold short.

Is Genenta Science's short interest increasing or decreasing?

Genenta Science saw a drop in short interest during the month of March. As of March 15th, there was short interest totaling 1,300 shares, a drop of 13.3% from the previous total of 1,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Genenta Science's short interest compare to its competitors?

0.01% of Genenta Science's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Genenta Science: Gossamer Bio, Inc. (2.67%), COMPASS Pathways plc (8.61%), Candel Therapeutics, Inc. (9.98%), Design Therapeutics, Inc. (10.59%), Atea Pharmaceuticals, Inc. (4.15%), Corvus Pharmaceuticals, Inc. (12.21%), Immutep Limited (3.37%), Acelyrin, Inc. (6.41%), Annexon, Inc. (11.95%), iTeos Therapeutics, Inc. (4.15%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short Genenta Science stock?

Short selling GNTA is an investing strategy that aims to generate trading profit from Genenta Science as its price is falling. GNTA shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Genenta Science?

A short squeeze for Genenta Science occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GNTA, which in turn drives the price of the stock up even further.

How often is Genenta Science's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNTA, twice per month. The most recent reporting period available is March, 15 2025.




This page (NASDAQ:GNTA) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners